Abstract: Currently, the popularity of large language models (LLMs) for instance, ChatGPT from OpenAI and Gemini from Google is increasing greatly in our lives, due to their unparalleled performance ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...
Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...